These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1964 related items for PubMed ID: 23924192

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. When should HAART be initiated in pregnancy to achieve an undetectable HIV viral load by delivery?
    Read PJ, Mandalia S, Khan P, Harrisson U, Naftalin C, Gilleece Y, Anderson J, Hawkins DA, Taylor GP, de Ruiter A, London HIV Perinatal Research Group.
    AIDS; 2012 Jun 01; 26(9):1095-103. PubMed ID: 22441248
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Factors associated with viral load suppression in HIV-infected pregnant women in Rio de Janeiro, Brazil.
    Joao EC, Gouvêa MI, Menezes JA, Sidi LC, Cruz ML, Berardo PT, Ceci L, Cardoso CA, Teixeira Mde L, Calvet GA, Matos HJ.
    Int J STD AIDS; 2012 Jan 01; 23(1):44-7. PubMed ID: 22362687
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and tolerability of nevirapine- versus efavirenz-containing regimens in HIV-infected Thai children.
    Lapphra K, Vanprapar N, Chearskul S, Phongsamart W, Chearskul P, Prasitsuebsai W, Chokephaibulkit K.
    Int J Infect Dis; 2008 Nov 01; 12(6):e33-8. PubMed ID: 18573672
    [Abstract] [Full Text] [Related]

  • 10. Factors associated with mortality among persistently viraemic triple-antiretroviral-class-experienced patients receiving antiretroviral therapy in the HIV Outpatient Study (HOPS).
    Palella FJ, Armon C, Buchacz K, Chmiel JS, Novak RM, D'Aquila RT, Brooks JT, HOPS Investigators.
    J Antimicrob Chemother; 2014 Oct 01; 69(10):2826-34. PubMed ID: 24942257
    [Abstract] [Full Text] [Related]

  • 11. Short-term antiretroviral therapy to prevent mother-to-child transmission is safe and results in a sustained increase in CD4 T-cell counts in HIV-1-infected mothers.
    Palacios R, Senise J, Vaz M, Diaz R, Castelo A.
    HIV Med; 2009 Mar 01; 10(3):157-62. PubMed ID: 19245537
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: a nationwide population-based cohort study.
    Larsen MV, Omland LH, Gerstoft J, Røge BT, Larsen CS, Pedersen G, Obel N, Kronborg G.
    Scand J Infect Dis; 2010 Dec 01; 42(11-12):917-23. PubMed ID: 20840000
    [Abstract] [Full Text] [Related]

  • 19. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
    Tai JH, Udoji MA, Barkanic G, Byrne DW, Rebeiro PF, Byram BR, Kheshti A, Carter JD, Graves CR, Raffanti SP, Sterling TR.
    J Infect Dis; 2007 Oct 01; 196(7):1044-52. PubMed ID: 17763327
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 99.